Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001236927-25-000005
Filing Date
2025-08-13
Accepted
2025-08-13 17:45:49
Documents
1
Period of Report
2025-08-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1755121546.html 4  
1 FORM 4 wk-form4_1755121546.xml 4 29933
  Complete submission text file 0001236927-25-000005.txt   31508
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O INCYTE CORPORATION 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803
Business Address
FRIEDMAN PAUL A (Reporting) CIK: 0001236927 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 251213244